Xencor appoints Nancy Valente to board; Yujiro Hata resigns

Xencor Inc

Nancy Valente, M.D., appointed to Board on Sept 8, 2022; she brings 20+ yrs pharma experience.
Yujiro Hata's resignation accepted by Board on Sept 8, 2022; he served since 2015.
Valente receives initial option grant valued at $550k (Black-Scholes) plus $50k annual cash retainer.
Valente most recently SVP at Genentech/Roche, led global oncology/hematology product development.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Yujiro S. Hata

Director

XNCR · Xencor Inc

Effective: 2022-09-08
Filed: September 9, 2022, 7:59 PM ET

On June 23, 2022, Yujiro S. Hata tendered his offer of resignation from the Board of Directors (the “Board”) of Xencor, Inc. (the “Company”), subject to the Board’s acceptance of his resignation. On September 8, 2022, the Board accepted Mr. Hata’s resignation.

Appointed

Nancy Valente

Director

XNCR · Xencor Inc

Effective: 2022-09-08
Filed: September 9, 2022, 7:59 PM ET

On September 8, 2022, Nancy Valente was appointed to the Board of the Company.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Yujiro S. Hata resigned as Director at Xencor Inc.

Action: resigned
Role: Director

Exact text from the filing

On June 23, 2022, Yujiro S. Hata tendered his offer of resignation from the Board of Directors (the “Board”) of Xencor, Inc. (the “Company”), subject to the Board’s acceptance of his resignation. On September 8, 2022, the Board accepted Mr. Hata’s resignation.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 1.0

Nancy Valente was appointed as Director at Xencor Inc.

Action: appointed
Role: Director

Exact text from the filing

On September 8, 2022, Nancy Valente was appointed to the Board of the Company.

View on SEC.gov

Xencor Inc filing history →

Source: SEC EDGAR

accession 0001558370-22-014299

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.